Electric convulsive therapy (ECT) increases plasma and red blood cell haloperidol neuroleptic activities.
In nine schizophrenic patients (five males and four females) on haloperidol treatment, plasma and red blood cell (RBC) haloperidol neuroleptic activities were measured before and after ECT by radioreceptor assay. Five patients randomly selected from these patients also served as controls on another occasion and neuroleptic activities in plasma and RBC were examined before and after the premedication only. All patients given ECT showed a considerable increase in plasma and RBC haloperidol neuroleptic activities after ECT (% increase in plasma neuroleptic activity, 28-409%; mean + SD, 136 +/- 155%, P less than 0.005, Wilcoxon test; % increase in RBC neuroleptic activity, 11-121%; mean + SD, 59 +/- 40%, P less than 0.005). However, no significant increase was observed for either plasma or RBC haloperidol neuroleptic activity, when patients were examined after premedication only. It was suggested that ECT induced a transient redistribution of haloperidol. It remains to be studied whether this phenomenon is causally related to the previous observation that the combination therapy of ECT and neuroleptics is more effective in the treatment of schizophrenia than ECT alone.
D000328:Adult; D001921:Brain / Q000378:metabolism; D004565:Electroconvulsive Therapy; D004912:Erythrocytes / Q000032:analysis*; D005260:Female; D006220:Haloperidol / Q000097:blood*; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000628:therapy
D006220:Haloperidol